Cargando…
Deep post-GWAS analysis identifies potential risk genes and risk variants for Alzheimer’s disease, providing new insights into its disease mechanisms
Alzheimer’s disease (AD) is a genetically complex, multifactorial neurodegenerative disease. It affects more than 45 million people worldwide and currently remains untreatable. Although genome-wide association studies (GWAS) have identified many AD-associated common variants, only about 25 genes are...
Autores principales: | Wang, Zhen, Zhang, Quanwei, Lin, Jhih-Rong, Jabalameli, M. Reza, Mitra, Joydeep, Nguyen, Nha, Zhang, Zhengdong D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519945/ https://www.ncbi.nlm.nih.gov/pubmed/34654853 http://dx.doi.org/10.1038/s41598-021-99352-3 |
Ejemplares similares
-
HEDD: Human Enhancer Disease Database
por: Wang, Zhen, et al.
Publicado: (2018) -
Integrated rare variant-based risk gene prioritization in disease case-control sequencing studies
por: Lin, Jhih-Rong, et al.
Publicado: (2017) -
Genomic expansion of Aldh1a1 protects beavers against high metabolic aldehydes from lipid oxidation
por: Zhang, Quanwei, et al.
Publicado: (2021) -
Network analysis of mitonuclear GWAS reveals functional networks and tissue expression profiles of disease-associated genes
por: Johnson, Simon C., et al.
Publicado: (2016) -
Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids
por: Jabalameli, M. Reza, et al.
Publicado: (2022)